Arthur Michael Feldman
Fundador en CardioKine, Inc. .
Cargos activos de Arthur Michael Feldman
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Director/Miembro de la Junta | 04/06/1998 | - |
| Fundador | 04/06/1998 | - | |
| Presidente | - | - | |
| Sidney Kimmel Medical College | Presidente | - | - |
Renovacor Holdings, Inc.
 Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | Director/Miembro de la Junta | - | - |
| Fundador | - | - |
Historial de carrera de Arthur Michael Feldman
Antiguos cargos conocidos de Arthur Michael Feldman.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
TouchStone Research, Inc.
 TouchStone Research, Inc. Miscellaneous Commercial ServicesCommercial Services TouchStone Research, Inc. (formerly known as Clinical Cardiovascular Research LLC) provides contract research services to pharmaceutical and medical device companies developing cardiovascular therapies. Its services include product development consulting, clinical trial design & execution, data analysis & report writing and other services to help health care companies move their heart-helping product candidates through the development & regulatory approval process. It was founded in 1997 and is headquartered in Gaithersburg, MD | Director/Miembro de la Junta | - | 23/10/2007 |
| RENOVACOR, INC. | Fundador | 07/06/2013 | - |
| The Johns Hopkins University | Director/Miembro de la Junta | - | - |
Formación de Arthur Michael Feldman.
| Gettysburg College | Undergraduate Degree |
| Louisiana State University | Graduate Degree |
| University of Maryland | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 10 |
Operativa
| Director/Board Member | 4 |
| Founder | 3 |
| Undergraduate Degree | 1 |
Sectorial
| Consumer Services | 6 |
| Health Technology | 4 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
TouchStone Research, Inc.
TouchStone Research, Inc. Miscellaneous Commercial ServicesCommercial Services TouchStone Research, Inc. (formerly known as Clinical Cardiovascular Research LLC) provides contract research services to pharmaceutical and medical device companies developing cardiovascular therapies. Its services include product development consulting, clinical trial design & execution, data analysis & report writing and other services to help health care companies move their heart-helping product candidates through the development & regulatory approval process. It was founded in 1997 and is headquartered in Gaithersburg, MD | Commercial Services |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | Health Technology |
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |
